个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共10条记录  
  • Novel congenital myopathy locus identified in Native American Indians at 12q13.13-14.1
    [作者:Stamm, DS; Powell, CM; Stajich, JM; Zismann, VL; Stephan, DA; Chesnut, B; Aylsworth, AS; Kahler, SG; Deak, KL; Gilbert, JR; Speer, MC,期刊:Neurology, 页码:1764-1769 , 文章类型: Article,,卷期:2008年71-22]
  • Background: Native American myopathy (NAM) is an autosomal recessive congenital myopathy first reported in the Lumbee Indian people. Features of NAM include congenital weakness, cleft palate, ptosis, short stature, and s...
  • Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
    [作者:Sorenson, EJ; Windbank, AJ; Mandrekar, JN; Bamlet, WR; Appel, SH; Armon, C; Barkhaus, PE; Bosch, P; Boylan, K; David, WS; Feldman, E; Glass, J; Gutmann, L; Katz, J; King, W; Luciano, CA; McCluskey, LF; Nash, S; Newman, DS; Pascuzzi, RM; Pioro, E; Sams, LJ; Scelsa, S; Simpson, EP; Subramony, SH; Tiryaki, E; Thornton, CA,期刊:Neurology, 页码:1770-1775 , 文章类型: Article,,卷期:2008年71-22]
  • Background: Previous human clinical trials of insulin-like growth factor type I (IGF-1) in amyotrophic lateral sclerosis (ALS) have been inconsistent. This phase III, randomized, double-blind, placebo-controlled study wa...
  • Cognitive profiles in dementia Alzheimer disease vs healthy brain aging
    [作者:Johnson, DK; Storandt, M; Morris, JC; Langford, ZD; Galvin, JE,期刊:Neurology, 页码:1783-1789 , 文章类型: Article,,卷期:2008年71-22]
  • Objective: To re-examine proposed models of cognitive test performance that concluded separate factor structures were required for people with Alzheimer disease (AD) and older adults without dementia.Methods: Five models...
  • Progression of dopaminergic dysfunction in a LRRK2 kindred A multitracer PET study
    [作者:Nandhagopal, R; Mak, E; Schulzer, M; McKenzie, J; McCormick, S; Sossi, V; Ruth, TJ; Strongosky, A; Farrer, MJ; Wszolek, ZK; Stoessl, AJ,期刊:Neurology, 页码:1790-1795 , 文章类型: Article,,卷期:2008年71-22]
  • Objective: Little is known about the progression of dopaminergic dysfunction in LRRK2-associated Parkinson disease (PD). We sought to characterize the neurochemical progression with multitracer PET in asymptomatic member...
  • Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
    [作者:Borroni, B; Malinverno, M; Gardoni, F; Alberici, A; Parnetti, L; Premi, E; Bonuccelli, U; Grassi, M; Perani, D; Calabresi, P; Di Luca, M; Padovani, A,期刊:Neurology, 页码:1796-1803 , 文章类型: Article,,卷期:2008年71-22]
  • Objective: In CSF, extended (55 kDa) and truncated (33 kDa) tau forms have been previously recognized, and the tau 33 kDa/55 kDa ratio has been found significantly reduced in progressive supranuclear palsy (PSP) vs in ot...